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A B S T R A C T   
Benzimidazole (BZ) drugs are frequently used to treat infections with the equine ascarid Parascaris univalens due 
to increasing resistance to macrocyclic lactones and pyrantel. Benzimidazole resistance is rare in ascarids in 
contrast to strongyle parasites where this resistance is widespread. In strongyles, single nucleotide poly-
morphisms (SNPs) at codons 167, 198 and 200 in a β-tubulin gene have been correlated to BZ resistance, but little 
is known about the β-tubulin genes and their possible involvement in BZ resistance in P. univalens and other 
ascarids. Previously two β-tubulin genes have been identified in P. univalens. In this study, we present five 
additional β-tubulin genes as well as the phylogenetic relationship of all seven genes to β-tubulins of other clade 
III and V nematodes. In addition, the efficacy of fenbendazole for treatment of P. univalens on a Swedish stud 
farm was studied in 2019 and 2020 using faecal egg count reduction test. Reductions varied from 73% to 88%, 
indicating the presence of a resistant P. univalens population on the farm. The emergence of BZ resistance em-
phasizes the need for development of molecular markers for rapid and more sensitive detection of resistant 
populations. We therefore investigated whether possible SNPs at positions 167, 198 or 200 in any of the β-tubulin 
genes could be used to distinguish between resistant and susceptible P. univalens populations. Amplicon 
sequencing covering the mutation sites 167, 198 and 200 in all seven β-tubulin genes revealed an absence of 
SNPs in both resistant and susceptible populations, suggesting that the mechanism behind BZ resistance in as-
carids is different from that in strongyle nematodes and the search for a molecular marker for BZ resistance in 
P. univalens needs to continue.   
1. Introduction 
The equine roundworm Parascaris univalens is a parasitic nematode 
that frequently infects foals and yearlings. Clinical signs include respi-
ratory symptoms such as coughing and nasal discharge, lethargy, weight 
loss and impaired growth. In severe cases impaction and even rupture of 
the small intestine may occur and can be lethal (Clayton and Duncan, 
1978; Cribb et al., 2006). Foals are usually treated regularly with 
anthelmintic drugs and anthelmintic resistance is therefore an 
increasing problem in P. univalens (Reinemeyer, 2009). Due to repeated 
reports of resistance to macrocyclic lactones (MLs) since 2002 (Boer-
sema et al., 2002; Osterman Lind and Christensson, 2009; Reinemeyer, 
2009) and more recently to pyrantel (PYR) (Lyons et al., 2008; Martin 
et al., 2018; Hautala et al., 2019), benzimidazoles (BZs) are currently the 
first choice of treatment for P. univalens infection in many countries. 
Despite frequent use of BZs, only a few cases of resistance have so far 
been reported in P. univalens (Armstrong et al., 2014; Alanazi et al., 
2017). In Ascaris lumbricoides and Ascaridia dissimilis, the ascarid para-
sites of humans and turkeys, single cases of reduced efficacy have been 
noted (Collins et al., 2019; Krucken et al., 2017), while there have been 
no reported cases of resistance in the poultry and pig roundworms 
Ascaridia galli and Ascaris suum (Tarbiat et al., 2017; Zhao et al., 2017). 
This is in contrast to strongyle nematodes where resistance to BZ drugs 
appeared soon after introduction of the first BZ on the market and are 
now considered the most widespread type of anthelmintic resistance 
(Conway, 1964; Saunders et al., 2013). 
Benzimidazole drugs act by binding to β-tubulin molecules, causing a 
conformational change and thereby hindering the polymerization of α- 
and β-tubulins in the construction of microtubules and other essential 
cellular components. This results in disruption of several essential 
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functions of the cell, leading to starvation and death of the parasite 
(Lacey, 1990). Most nematodes have several β-tubulin genes, usually 
referred to as isotypes, and there is compelling evidence that single 
nucleotide polymorphisms (SNPs) in the β-tubulin isotype 1 gene are 
involved in BZ resistance in strongyle nematodes (von 
Samson-Himmelstjerna et al., 2007). In the sheep parasite Haemonchus 
contortus a SNP resulting in amino acid substitution from phenylalanine 
to tyrosine at position 200 was first identified and linked to BZ resistance 
and is believed to be the principal cause of BZ resistance in this species 
(Kwa et al., 1994). However, SNPs causing amino acid substitutions 
from phenylalanine to tyrosine at position 167 and from glutamate to 
alanine or leucine at position 198 have also been correlated to BZ 
resistant phenotypes (Silvestre and Cabaret, 2002; Ghisi et al., 2007; 
Redman et al., 2015; Avramenko et al., 2019). In addition, it has been 
suggested that mutations in the isotype 1 gene are not solely responsible, 
but that BZ resistance may be multi-genic. For example, SNPs in the 
H. contortus β-tubulin isotype 2 gene have been correlated to BZ resis-
tance in field strains (Kwa et al., 1993a, 1993b) and BZ drugs have also 
been shown to influence the expression of drug metabolizing enzymes 
and drug efflux pumps (Beugnet et al., 1997; Laing et al., 2010; Jones 
et al., 2013; Kellerova et al., 2020). 
Although it is generally accepted that the main molecular target for 
BZ anthelmintics in nematodes is β-tubulin, the knowledge of the di-
versity of the tubulin family has increased in recent years, indicating 
that the level of complexity is higher than previously thought (Kotze 
et al., 2014). For example, the model organism Caenorhabditis elegans 
has six β-tubulin genes (Gogonea et al., 1999), though only one of these, 
ben-1, is a drug target for BZs (Driscoll et al., 1989). Several mutations in 
this gene have been reported to confer BZ resistance, including the 
polymorphisms described above in the β-tubulin isotype 1 gene (Driscoll 
et al., 1989; Dilks et al., 2020). Saunders et al. (2013) presented a 
thorough investigation of the β-tubulin family of H. contortus and found 
that it consists of four isotypes and that isotypes 1 and 2 have a paral-
ogous relationship to C. elegans ben-1, tbb-1 and tbb-2. In Parascaris spp. 
two β-tubulin genes have been identified so far, at the time named iso-
type 1 and isotype 2 (Tyden et al., 2013). However, since these showed 
phylogenetic diversity compared to β-tubulin genes of nematodes of 
other genus these names may be misleading and will not be used further 
in this paper. In the related poultry roundworm A. galli six β-tubulin 
genes have been identified (Martis et al., 2017). 
The possible presence of resistance associated SNPs in β-tubulin 
genes have also been investigated in ascarid worms. None of the pre-
viously described polymorphisms were found in either of the two 
β-tubulin genes in BZ-susceptible Parascaris spp. (Tyden et al., 2013, 
2014) and similarly Tarbiat et al. (2017) found no SNPs in a β-tubulin 
gene of BZ-susceptible A. galli. In A. lumbricoides, no SNPs could be 
detected at any of the sites of four β-tubulin genes in a population with a 
reduced efficacy of the BZ albendazole (Krucken et al., 2017). However, 
Diawara et al. (2009) found a polymorphism at position 167 in a 
β-tubulin gene of an albendazole-susceptible population and Furtado 
et al. (2019) found a mutation at codon 200 at 0.5% allele frequency in a 
population with unknown resistance status. 
There have been several efforts to develop methods to use SNPs in 
the β-tubulin isotype 1 gene as molecular markers for detection of 
anthelmintic resistance, using techniques such as quantitative PCR, 
pyrosequencing, droplet digital PCR and amplicon sequencing (Alvar-
ez-Sanchez et al., 2005; von Samson-Himmelstjerna, 2006; Baltrusis 
et al., 2018; Avramenko et al., 2019). A molecular maker for BZ resis-
tance in P. univalens would allow easy and rapid screening of foal faecal 
samples to identify resistance to BZ, rather than the more laborious 
Faecal Egg Count Reduction Test (FECRT). In addition, since resistance 
can only be detected by FECRT when the proportion of the parasite 
population carrying the resistance gene exceeds 25%, a molecular 
marker would make earlier detection of resistance possible compared to 
using FECRT (Martin et al., 1989). 
In this study we present the seven genes in the P. univalens β-tubulin 
family and their phylogenetic relationship to β-tubulin genes of other 
clade III and V nematodes. We have identified a population of BZ- 
resistant P. univalens at a Swedish stud farm using FECRT and used 
this unique population to search for previously described SNPs at codons 
167, 198 and 200 in the seven β-tubulin genes. 
2. Materials and methods 
2.1. Farms, foals and collection of parasite material 
Research ethics committee oversight was not required for this 
research according to the Swedish National Board of Agriculture (SJVFS, 
2019:9, L159). Written owner informed consent was obtained for all 
included animals. 
In total 63 foals from two farms (farm 1 and farm 2) were included in 
FECRTs and used to collect parasite eggs for amplicon sequencing. Data 
on the included farms and foals are shown in Table 1. 
Farm 1 monitor egg counts for P. univalens at monthly intervals and 
treat foals with ≥100 Eggs Per Gram faeces (EPG). Fenbendazole (FBZ) 
has been used to treat the foals on the farm for approximately 15 years. A 
FECRT was performed with foals on the farm in two consecutive years. 
In 2019, 16 foals between five and nine months of age were included 
(group A). In 2020, 35 foals (group B) and 11 foals (group C) between 
three and six months of age were included. Eggs excreted after treatment 
with FBZ were collected from all groups for amplicon sequencing. 
Farm 2 has a documented 100% efficacy of FBZ (Martin et al., 2018) 
and was included to serve as a control for the amplicon sequencing. A 
FECRT was performed in 2020 and included four foals between five and 
six months of age (group D). Eggs from all included foals were collected 
pre-treatment and used for amplicon sequencing. 
2.2. Faecal Egg count reduction test 
Individual faecal samples were collected from the foals described 
above, placed in double plastic bags and posted to our laboratory 
(Section for Parasitology, Swedish University of Agricultural Sciences). 
Paired faecal egg counts were performed pre- (day 0) and post-treatment 
(day 11–20) using a modified McMaster technique with a minimum 
detection limit of 50 EPG (Coles et al., 1992). All foals excreted ≥100 
EPG and were treated with FBZ paste (Axilur® MSD, Kenilworth, USA) 
at a dosage of 7.5 mg/kg as recommended by the manufacturer. All foals 
were weighed or measured to estimate the weight and the anthelmintic 
drug was dosed for additional 50 kg to avoid under dosing. Faecal 
sampling, weighing and treatment were performed by experienced stud 
personnel. The faecal egg count reduction was calculated on paired 
samples by a Bayesian hierarchical model on the shiny-eggCounts web 
interface (Torgerson et al., 2014). The results were interpreted accord-
ing to suggested cutoff values for strongyle nematodes by the American 
Association of Equine Practitioners (AAEP) (Nielsen et al., 2019) as 
there are currently no specific guidelines for P. univalens FECRT. 
2.3. Examination of the β-tubulin family 
2.3.1. Identification of β-tubulin genes in the P. univalens genome 
β-tubulin genes were identified from the functional annotation of 
RNA-Seq data (PRJEB37010) (Martin et al., 2020). Manual BLAST 
searches in the P. univalens genome (PRJNA386823) (Wang et al., 2017) 
in WormBase Parasite (Howe et al., 2017) using the RNA-Seq genes as 
template did not identify any additional β-tubulin genes. All identified 
sequences were confirmed to contain a β-tubulin chain by BLASTP 
searches in the NCBI database (Sayers et al., 2021). 
2.3.2. DNA extraction 
Eggs were isolated and decorticated according to Martin et al. 
(2018). For each group (A, B, C and D) approximately 30,000 eggs were 
incubated 14 days at 28 ◦C for development into larvae, then genomic 
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DNA was prepared in two separate reactions for each group, using 
NucleoSpin® Tissue kit (Macherey Nagel, Düren, Germany) according to 
manufacturer’s instructions. DNA concentration was determined using 
Qubit BRDNA kit (Invitrogen, Carlsbad, USA). 
2.3.3. Primer design and validation 
Primer3 web (Untergasser et al., 2012) was used to design primers 
for amplicons containing SNP sites 167, 198 and 200 in each of the seven 
β-tubulin genes (Table 2). Due to differences in intron length between 
the β-tubulin genes, the expected amplicon size ranged from 559 to 1834 
bp. Unique barcodes to identify genes and groups were added to the 
primers. Primers of NGS quality were ordered from Eurofins Genomics 
(Galten, Denmark). To confirm primer specificity PCR reactions con-
taining: 12.5 μl Accustart II PCR ToughMix (Quanta bio, Beverly, USA), 
1 μl F Primer (10 μM), 1 μl R primer (10 μM), 9.5 μl H2O and 1 ng 
template DNA were prepared and performed at 94 ◦C for 3 min, followed 
by 35 cycles of 94 ◦C for 30 s, 58 ◦C for 30 s and 72 ◦C for 90 s with a final 
extension at 72 ◦C for 9 min. PCR products were confirmed by gel 
electrophoresis, Sanger sequencing (Macrogen Europe, Amsterdam, 
Netherlands) and alignments in MUSCLE Multiple Sequence Alignment 
(Madeira et al., 2019). 
2.3.4. Amplicon generation and sequencing 
To minimize PCR bias two reactions were performed for each 
β-tubulin gene. Amplicons were generated using 30 μl Phusion Hot Start 
II High-Fidelity PCR Master Mix (Thermo Fisher Scientific, Waltham, 
USA), 3 μl of each specific barcoded primer (10 μM), 15 ng of specific 
DNA and molecular grade water (Qiagen, Hilden, Germany) up to 60 μl. 
PCR reactions were run on Applied Biosystems (Foster City, USA) 2721 
Thermal Cycler for 1 min at 98 ◦C followed by 24 cycles of 10 s at 98 ◦C 
and 45 s at 72 ◦C with a final extension for 10 min at 72 ◦C. Amplicons 
were purified using AMPure XP magnetic beads (Beckman Coulter Inc., 
Brea, USA) according to the manufacturer’s instructions (0.8 x). DNA 
concentration was determined using Qubit BRDNA kit. To get a similar 
number of amplicons for each gene in the multiplex library the amount 
of each amplicon in the final library was calculated based on amplicon 
size and concentration and then pooled. 
After quality control using TapeStation (Agilent, Santa Clara, USA), 
500 ng of total amplicon metabarcoded pool was sequenced on a SMRT 
cell (Pacific Biosciences, Meleno Park, USA) using the PacBio Sequel 
Technology Platform (Uppsala Genome Center (UGC), Science for Life 
Laboratory, Dept. of Immunology, Genetics and Pathology, Uppsala 
University, BMC, Box 815, SE-752 37 UPPSALA). 
2.3.5. NGS data analysis 
Initial raw PacBio sub-read datasets were processed to generate un-
aligned Circular Consensus Sequence (CCS) reads with the SMRT Link 
v9.0 (Pacific Biosciences) software pipeline using CCS application with 
default parameters. The CCS reads from all samples were mapped 
independently to the genes of interest in the P. univalens reference 
genome (PRJNA386823) with the SMRT pbmm2 tool kit (Pacific Bio-
sciences). Demultiplexing was performed on aligned CCS reads to 
retrieve independent sample reads. Variant calling (SNP and Indels) was 
performed with GATK4v4 HaplotypeCaller (DePristo et al., 2011) and 
multi-sample variant calling was performed for each group (A, B, C and 
D) using CombineGVCFs and GenotypeGVCFs functions. 
2.3.6. De novo assembly of β-tubulin genes 
To extend the incomplete coding sequence of PgB04_g136 available 
in WormBase Parasite (Howe et al., 2017) RNA-Seq data (PRJEB37010) 
from Martin et al. (2020) was used for a de novo transcriptome assembly 
using Trinity version 2.11 (Grabherr et al., 2011) including the PacBio 
β-tubulin reads as extra support. The transcriptome was turned into a 
BLAST database using blast + version 2.6.0+ (Camacho et al., 2009). 
Table 1 
Data on farms included in faecal egg count reduction test and amplicon sequencing.  














% of foals 
excreting ≥50 
EPGb 
% of foals with 
increasing EPGc 
1 A 2019 16 5–9 560 125 1500 800 78 38 6 
1 B 2020 35 3–6 1939 523 7350 3000 73 74 23 
1 C 2020 11 3–6 1968 232 5200 1600 88 36 0 
2 D 2020 4 5–6 1725 0 2800 0 100 0 0  
a Pre- and post-treatment egg counts. 
b Percentage of foals excreting 50 EPG or more post-treatment. 
c Percentage of foals with higher EPG post treatment than pre-treatment. 
Table 2 
Parascaris univalens β-tubulin genes, primers used for sequencing and amplicon sizes.  
Putative gene name WormBase Parasite ID Amplicon sequencing primers Amplicon size (bp) 
tbb-3 PgB04_g135 F: GCGAGCGTATGGAAAGAGAG 
R: AGCAAAGAGCTGATGGTCGT 
1834 
tbb-4a PgB04_g136 F: TCGGAATCCATAAGCTCTGC 
R: CTTGCGATTTGATTGGAACA 
559 
tbb-5b PgR007_g022 F: TGTGAGAAAATGCCATCGTG 
R: GCAACCTCCATCCGAATACT 
685 
tbb-6c PgE153_g002 F: ATTGCTGAAGGTTTGGTTCG 
R: CTCCGATTTCGTTGCTTCTC 
1246 
tbb-7 PgB10_g062 F: CAACAAAGCTCGTTTTGAAGG 
R: TTAATGCAACGACGTTCCTG 
997 
tbb-8 PgR003_g161 F: CACGCTTCGCTCTTCTTAGG 
R: ATCGGCACAAAAATGGAAAC 
840 
tbb-9 PgR045_g070 F: TTCAAACAACGGCGATGATA 
R: AATTTCACATCTCCGGATGC 
971  
a Incomplete readingframe in WormBase Parasite. 
b Previously described as β-tubulin isotype 1 (KC713797). 
c Previously described as β-tubulin isotype 2 (KC713798). 
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Parascaris univalens β-tubulin mRNA sequences were retrieved from 
WormBase Parasite (Howe et al., 2017) release 15, Oct 2020 and aligned 
against the transcriptome database to identify β-tubulin transcripts. The 
results were processed by wrapping up code published in the 
UPSCb-common repository (https://doi.org/10.5281/zenodo. 
4001774), as described in this manuscripts companion code repository 
(https://github.com/SLUBioinformaticsInfrastructure/parascaris-proje 
ct). 
2.3.7. Phylogenetic analysis 
Sequences homologous to P. univalens β-tubulin genes were retrieved 
from WormBase Parasite (Howe et al., 2017) and the protein sequences 
were obtained using Transdecoder v5.5.0 (https://github.com/TransD 
ecoder/TransDecoder). β-tubulin sequences for clade III and V para-
sites A. lumbricoides, A. suum, Toxocara canis, Brugia malayi, H. contortus, 
Necator americanus and Onchocerca volvulus were included provided they 
had a reciprocal percentage identity over 60% and a full-length coding 
sequence in WormBase Parasite (Howe et al., 2017). Sequences for the 
complete C. elegans β-tubulin family were retrieved from WormBase 
(Harris et al., 2020) version WS280, however Cel-tbb-6 was excluded 
from the analysis to avoid long branch attraction (Saunders et al., 2013) 
(Table 3). Saccharomyces cerevisiae β-tubulin mRNA (NP_116616.1) was 
used as outgroup. 
The phylogenetic analysis was performed on the Phylogeny.fr plat-
form, advanced mode, using default settings (Dereeper et al., 2008, 
2010). Sequences were aligned using MUSCLE (v3.7), then regions 
containing gaps or poorly aligned sequence were removed with Gblocks 
(v0.91b) using the less stringent selection (Castresana, 2000; Edgar, 
2004). The phylogenetic relationship between the sequences was ana-
lysed using the maximum likelihood method implemented in PhyML 
(v3.0) using the default substitution model (Guindon and Gascuel, 2003; 
Anisimova and Gascuel, 2006). Graphical representation and editing of 
the phylogenetic tree were performed with TreeDyn (v198.3) (Chevenet 
et al., 2006). Finally, the R package ggtree was used to visualise the 
reconstructed tree (Yu, 2020). 
3. Results 
3.1. Faecal egg count reduction test 
Group A, B and C on farm 1 had observed efficacies of 78%, 73% and 
88% respectively (Table 1), which is below the resistance threshold of 
90% suggested by the AAEP (Nielsen et al., 2019). The proportion of 
foals shedding eggs at the post-treatment sampling was 38% in group A, 
74% in group B and 36% in group C (Table 1). In addition, 6% of the 
foals in group A and 23% of the foals in group B shed more eggs 
post-treatment than pre-treatment. In group D on farm 2 the observed 
efficacy was 100% (Table 1). 
3.2. Identification of β-tubulin genes and phylogenetic analysis 
Seven β-tubulin genes were identified based on functional annotation 
of RNA-Seq data (PRJEB37010) from one of our previous projects 
(Table 2). Two of these, PgR007_g022 and PgE153_g002 corresponded 
to the previously described β-tubulin genes (Tyden et al., 2013) while 
the remaining five were novel β-tubulin genes. All seven genes were 
confirmed β-tubulins by BLASTP searches in the NCBI database (Sayers 
et al., 2021). All β-tubulin genes had complete reading frames in 
WormBase Parasite apart from PgB04_g136, which was extended to 
contain the full coding sequence by a de novo assembly using RNA-Seq 
data as above combined with PacBio data from the amplicon 
sequencing. 
The phylogeny of the seven β-tubulin genes from P. univalens were 
compared to full length β-tubulin genes from eight other nematodes 
belonging to clade III and clade V and formed four major clusters (Fig. 1, 
Table 3). Genes from both clades formed two different clusters 
containing isotypes 3 and 4. PgB04_g135 was putatively named Pun-tbb- 
3 since it clustered with Hco-tbb-iso-3 and C. elegans mec-7. Genes from 
all species included in the analysis were present in this tbb-3-cluster, 
apart from N. americanus, possibly due to the lack of a full length 
sequence in WormBase Parasite for this gene. Similarly, PgB04_g136 
was putatively named Pun-tbb-4 since it formed a cluster with Hco-tbb- 
iso-4 and C. elegans tbb-4. In this tbb-4-cluster, genes from all included 
species except A. lumbricoides were present, again possibly due to the 
lack of a full length sequence in WormBase Parasite. In addition, two 
separate clusters were formed by clade III and clade V β-tubulin genes. In 
the clade V-cluster H. contortus isotype 1 and isotype 2 as well as 
C. elegans ben-1, Cel-tbb-1 and Cel-tbb-2 grouped together. In a separate 
cluster the two previously described β-tubulin genes PgR007_g022 and 
PgE153_g002 as well as the novel PgB10_g062, PgR003_g161 and 
PgR045_g070, putatively named Pun-tbb-5, Pun-tbb-6, Pun-tbb-7, Pun- 
tbb-8 and Pun-tbb-9, grouped with previously unnamed β-tubulin genes 
from clade III nematodes including ascarids (Fig. 1, Table 3). 
3.3. Amplicon sequencing 
All seven β-tubulin genes of P. univalens were examined for the 
presence of resistance associated SNPs at position 167, 198 and 200 in 
samples from three groups with reduced efficacy of FBZ (farm 1 - group 
A, B and C) and one group with 100% efficacy of FBZ (farm 2 - group D). 
PacBio sequencing yielded between 1741 and 20,611 consensus reads 
for each amplicon. 
No sequence polymorphisms were identified in any of the examined 
sites when compared between farms with resistant phenotype, farms 
with susceptible phenotype and the P. univalens reference genome from 
WormBase Parasite. However, Pun-tbb-7 (PgB10_g062) contained a 
tyrosine at position 200 in samples from all groups as well as in the 
reference genome. 
4. Discussion 
This is the first report of FBZ resistance in P. univalens in Sweden and 
Europe. Since resistance to MLs is considered to be widespread in 
Sweden (Lindgren et al., 2008; Osterman Lind and Christensson, 2009) 
and resistance to PYR has been found on a number of farms (Martin 
et al., 2018), these results imply that multi-resistant P. univalens pop-
ulations may be present on Swedish stud farms. This increasing problem 
with anthelmintic resistance in P. univalens is a major threat to equine 
health and welfare, but also to the equine industry. The efficacy of FBZ 
has been monitored regularly in Sweden for the past 12 years, with re-
sults of 100% (Osterman Lind and Christensson, 2009; Tyden et al., 
2013) until 2018 when one farm was classed as resistant (Martin et al., 
2018). However, this was due to treatment failure of only two out of 13 
foals and therefore not considered as a clear case of FBZ-resistance at the 
time (Martin et al., 2018). In our current study, the same farm (farm 1) 
showed efficacies below the 90% resistance threshold (Nielsen et al., 
2019) in both 2019 and 2020 and these results were further supported 
by the fact that a large proportion of the foals excreted eggs post 
treatment. Resistance to BZ-drugs is rare in Parascaris spp. and has so far 
only been demonstrated in Australia (Armstrong et al., 2014) and Saudi 
Arabia (Alanazi et al., 2017). Therefore, this is a unique population for 
exploration of mechanisms behind BZ resistance in P. univalens. 
The rapid emergence of BZ resistance suggests that regular moni-
toring of drug efficacy is important, especially in P. univalens, since 
treatments are usually performed routinely without previous faecal ex-
amination. Since it has been suggested that FECRT only detect resistance 
when more than 25% of the population carries the resistance phenotype 
(Martin et al., 1989), development of alternative methods for early 
detection of resistance, such as molecular markers, is important. 
It is therefore valuable to explore the β-tubulin family of P. univalens 
and examine the genes for SNPs associated with resistance in other 
nematodes. Using RNA-Seq data from P. univalens, we found that the 
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Table 3 
Sequences used for phylogenetic analysis, blue indicates a clade V β-tubulin cluster, orange a cluster containing clade III β-tubulins. 
Isotype-3 cluster (green) and isotype-4 cluster (white) contain β-tubulins from both clade III and V. 
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β-tubulin family contains seven genes. We also investigated the phylo-
genetic relationship of these genes with β-tubulin genes from the model 
organism C. elegans and parasites of importance in clades III and V. Two 
β-tubulin genes have previously been described in P. univalens, and were 
then named isotype 1 and isotype 2 (Tyden et al., 2013). However, since 
it is now known that these genes are not orthologous to the strongyle 
β-tubulin isotype 1 and isotype 2 genes the names are misleading and we 
have therefore renamed them Pun-tbb-5 and Pun-tbb-6 in this article. The 
phylogenetic analysis show that the P. univalens β-tubulin genes 
Pun-tbb-5, Pun-tbb-6 Pun-tbb-7, Pun-tbb-8 and Pun-tbb-9 are situated in a 
clade together with other ascarid β-tubulins but separated from and 
equally related to Cel-ben-1, Cel-tbb-1 and Cel-tbb-2 as well as Hco-tb-
b-iso-1 and Hco-tbb-iso-2. Functional studies in C. elegans has shown that 
Cel-ben-1 is the only established drug target of BZs (Driscoll et al., 1989) 
and in H. contortus several studies support the involvement of Hco-tb-
b-iso-1 and also suggest that Hco-tbb-iso-2 is involved in BZ resistance 
(Kwa et al., 1993a; Rufener et al., 2009). Even though Cel-tbb-1 and 
Cel-tbb-2 are closely related to Cel-ben-1, they are suggested not to be 
targets for BZs as they carry a tyrosine in position 200, rather than the 
phenylalanine needed for BZ binding (Saunders et al., 2013). According 
to our results, the P. univalens β-tubulin genes Pun-tbb-3 and Pun-tbb-4 
are closely related to Hco-tbb-iso-3 and Cel-mec-7 as well as to Hco-tb-
b-iso-4 and Cel-tbb-4 respectively (Fig. 1). However, Cel-mec-7 and 
Cel-tbb-4 are only expressed in specific neurons and are therefore not 
considered to be involved in BZ binding or resistance (Savage et al., 
1989; Hurd et al., 2010). Saunders et al. (2013) concluded that the same 
is true for Hco-tbb-iso-3 and Hco-tbb-iso-4, and we therefore suggest a 
similar function for Pun-tbb-3 and Pun-tbb-4. We found that Pun-tbb-7 
carry a tyrosine at position 200 in samples from both resistant and 
susceptible phenotypes, as well as in the reference genome derived from 
a population of anthelmintic naïve P. univalens (Wang et al., 2017). 
Based on these results and the specific expression and relationship of 
isotype-3 and isotype-4 genes discussed above, our data suggest that 
Pun-tbb-3, Pun-tbb-4 and Pun-tbb-7 are most likely not targets for 
BZ-drugs in P. univalens. However, one or several of the genes Pun-tbb-5, 
Pun-tbb-6, Pun-tbb-8, or Pun-tbb-9 could be candidates for BZ drug-target 
and resistance in P. univalens as they are equally related to Cel-ben-1 and 
express a phenylalanine at position 200. 
We sequenced amplicons covering the mutation sites 167, 198 and 
200 in the seven β-tubulin genes from three pools of P. univalens larvae 
with a FBZ-resistant phenotype and one pool of larvae with a FBZ- 
susceptible phenotype. No SNPs at the positions responsible for BZ 
resistance in strongyles were identified in any of the seven β-tubulin 
genes, neither in the FBZ-resistant or susceptible phenotypes. These 
results are in line with results from Krucken et al. (2017) who found no 
resistance associated mutations in A. lumbricoides showing reduced ef-
ficacy of BZs. Since none of the SNPs associated with resistance in 
strongyle nematodes were identified in FBZ-resistant P. univalens the 
search for BZ resistance mechanism continues. Since as many as 28 
mutations in the C. elegans ben-1 gene were identified in connection to 
BZ resistance (Driscoll et al., 1989) there is a possibility that a mutation 
in another position could be responsible for BZ resistance in P. univalens. 
Any breakthroughs in this area would also be important in a one health 
aspect as P. univalens are closely related to A. lumbricoides that infects 
819 million people yearly, mainly children (Pullan et al., 2014). Since 
this parasite is treated by mass drug administration and reduced efficacy 
of BZ drugs has been noted (Krucken et al., 2017) there is an urgent need 
for molecular markers to identify resistance also in ascarids (Prichard, 
2007). 
5. Conclusions 
This is the first report of BZ-resistance in an ascarid parasite in 
Europe and the first presentation of the full β-tubulin family of an 
ascarid parasite. These results are of major importance for further 
exploration of BZ resistance in P. univalens, and possibly also in the 
related human ascarid parasite A. lumbricoides. 
Phylogenetic analysis indicates that Pun-tbb-5, Pun-tbb-6, Pun-tbb-8, 
Fig. 1. Phylogenetic tree of В-tubulin genes. The tree was constructed on the Phylogeny.fr platform, using a maximum likelihood based analysis of seven Par-
ascaris univalens В-tubulin genes and their full length homologues in Ascaris lumbricoides, Ascaris suum, Toxocara canis, Brugia malayi, Haemonchus contortus, Necator 
americanus and Onchocerca volvulus retrieved from WormBase Parasite and Caenorhabditis elegans obtained from WormBase. Saccharomyces cerevisiae was used as 
outgroup for the phylogenetic analysis. * Gene name from WormBase, all other gene names are putative (Table 3). 
F. Martin et al.                                                                                                                                                                                                                                  
International Journal for Parasitology: Drugs and Drug Resistance 17 (2021) 84–91
90
or Pun-tbb-9 could be candidates for BZ drug interaction and resistance 
in P. univalens, however more research is required to confirm this. 
Amplicon sequencing of the sites for resistance associated SNPs in 
strongyle nematodes, 167, 198 and 200, did not identify any poly-
morphisms in any of the P. univalens β-tubulin genes in samples from a 
farm with reduced efficacy to FBZ. This suggests that the mechanisms 
behind BZ resistance in ascarids are different than in strongyle 
nematodes. 
The rapid emergence of BZ resistance in P. univalens suggests that 
regular monitoring of drug efficacy is important since treatments are 
usually performed routinely without previous examination of faecal 
samples. Since resistance to all registered anthelmintic drugs have been 
identified in P. univalens it is also of great importance to improve bio-
security and hygiene measures on stud farms to lower infection pressure 
and spread of resistant parasites. 
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